Eugene is an Associate Consultant with a background in neuroimmunology. Eugene is an expert in neurological disorders, including chronic degenerative disorders, and consequences resultant from neural injury (TBI, spinal cord injury). He supports a range of strategy and business development assignments, including market and pipeline opportunity assessments, R&D and preclinical strategy, and competitive landscape analyses.
Eugene received his PhD in Neuroscience in 2019 from Drexel University College of Medicine specializing traumatic spinal cord injury. He subsequently did his post-doctoral fellowship at the University of Pennsylvania investigating mechanisms by which viral infection and cannabinoids affect chronic degenerative CNS pathology. He has presented his work at several international conferences. Eugene has experience working with 2- and 3-dimensional human-induced pluripotent stem cell culture systems and has extensive knowledge of genetic engineering and DNA/RNA sequencing.